
United Therapeutics Corporation
United Therapeutics Corporation(UTHR)内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签;可在本季度与近12个月之间切换;下方为季度图与交易明细。
SEC EDGAR · FMP · UTHR · 截至 2026年6月8日
活动摘要
买入笔数
1
P-Purchase only
卖出笔数
1735
近12个月
买卖比
0.00
Buy/Sell (by trades)
整体情绪
United Therapeutics Corporation内部人在过去近12个月主要在卖出股份,卖出行为通常由预设的Rule 10b5-1计划驱动,不一定代表对公司的负面看法。
▸ 数据来源:SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月8日
UTHR 季度内部人买卖趋势
UTHR 内幕交易卖出 · UTHR 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源:SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 8, 2026
活跃内部人
近12个月交易最活跃 · UTHR CEO内幕交易
显示全部内部人 · 点击卡片过滤下方交易表
▸ 按reportingName聚合 · 近12月交易次数Top5 · 无额外API
近期内幕交易记录
UTHR 高管卖出股份 · UTHR 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| Jun 4, 2026 | EDGEMOND JAMES CFO AND TREASURER | Option | 10,000 | $1.18M⚡ | Form 4 |
| Jun 4, 2026 | EDGEMOND JAMES CFO AND TREASURER | Sale | 120 | $65K | Form 4 |
| Jun 4, 2026 | EDGEMOND JAMES CFO AND TREASURER | Sale | 480 | $260K | Form 4 |
| Jun 4, 2026 | EDGEMOND JAMES CFO AND TREASURER | Sale | 440 | $239K | Form 4 |
| Jun 4, 2026 | EDGEMOND JAMES CFO AND TREASURER | Sale | 1,086 | $591K | Form 4 |
| Jun 4, 2026 | EDGEMOND JAMES CFO AND TREASURER | Sale | 1,545 | $842K | Form 4 |
| Jun 4, 2026 | EDGEMOND JAMES CFO AND TREASURER | Sale | 1,129 | $616K | Form 4 |
| Jun 4, 2026 | EDGEMOND JAMES CFO AND TREASURER | Sale | 1,033 | $565K | Form 4 |
| Jun 4, 2026 | EDGEMOND JAMES CFO AND TREASURER | Sale | 2,749 | $1.51M⚡ | Form 4 |
| Jun 4, 2026 | EDGEMOND JAMES CFO AND TREASURER | Sale | 1,298 | $713K | Form 4 |
| Jun 4, 2026 | EDGEMOND JAMES CFO AND TREASURER | Sale | 120 | $66K | Form 4 |
| Jun 4, 2026 | ROTHBLATT MARTINE A Chairperson & CEO · Director | Option | 9,500 | $1.39M⚡ | Form 4 |
| Jun 4, 2026 | ROTHBLATT MARTINE A Chairperson & CEO · Director | Sale | 120 | $65K | Form 4 |
| Jun 4, 2026 | ROTHBLATT MARTINE A Chairperson & CEO · Director | Sale | 473 | $256K | Form 4 |
| Jun 4, 2026 | ROTHBLATT MARTINE A Chairperson & CEO · Director | Sale | 112 | $61K | Form 4 |
| Jun 4, 2026 | ROTHBLATT MARTINE A Chairperson & CEO · Director | Sale | 396 | $215K | Form 4 |
| Jun 4, 2026 | ROTHBLATT MARTINE A Chairperson & CEO · Director | Sale | 1,470 | $800K | Form 4 |
| Jun 4, 2026 | ROTHBLATT MARTINE A Chairperson & CEO · Director | Sale | 1,186 | $647K | Form 4 |
| Jun 4, 2026 | ROTHBLATT MARTINE A Chairperson & CEO · Director | Sale | 1,202 | $656K | Form 4 |
| Jun 4, 2026 | ROTHBLATT MARTINE A Chairperson & CEO · Director | Sale | 1,525 | $835K | Form 4 |
| Jun 4, 2026 | ROTHBLATT MARTINE A Chairperson & CEO · Director | Sale | 1,676 | $919K | Form 4 |
| Jun 4, 2026 | ROTHBLATT MARTINE A Chairperson & CEO · Director | Sale | 780 | $428K | Form 4 |
| Jun 4, 2026 | ROTHBLATT MARTINE A Chairperson & CEO · Director | Sale | 560 | $308K | Form 4 |
| Jun 4, 2026 | MAHON PAUL A EVP & GENERAL COUNSEL | Option | 8,300 | $1.21M⚡ | Form 4 |
| Jun 4, 2026 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale | 200 | $108K | Form 4 |
ROTHBLATT MARTINE A
Chairperson & CEO · Director
日期
Jun 4
股数
9,500
均价
$146.03
总金额
$1.39M ⚡
ROTHBLATT MARTINE A
Chairperson & CEO · Director
日期
Jun 4
股数
120
均价
$539.51
总金额
$65K
ROTHBLATT MARTINE A
Chairperson & CEO · Director
日期
Jun 4
股数
473
均价
$541.08
总金额
$256K
ROTHBLATT MARTINE A
Chairperson & CEO · Director
日期
Jun 4
股数
112
均价
$542.50
总金额
$61K
ROTHBLATT MARTINE A
Chairperson & CEO · Director
日期
Jun 4
股数
396
均价
$543.11
总金额
$215K
ROTHBLATT MARTINE A
Chairperson & CEO · Director
日期
Jun 4
股数
1,470
均价
$544.24
总金额
$800K
ROTHBLATT MARTINE A
Chairperson & CEO · Director
日期
Jun 4
股数
1,186
均价
$545.18
总金额
$647K
ROTHBLATT MARTINE A
Chairperson & CEO · Director
日期
Jun 4
股数
1,202
均价
$546.14
总金额
$656K
ROTHBLATT MARTINE A
Chairperson & CEO · Director
日期
Jun 4
股数
1,525
均价
$547.53
总金额
$835K
ROTHBLATT MARTINE A
Chairperson & CEO · Director
日期
Jun 4
股数
1,676
均价
$548.26
总金额
$919K
ROTHBLATT MARTINE A
Chairperson & CEO · Director
日期
Jun 4
股数
780
均价
$549.24
总金额
$428K
ROTHBLATT MARTINE A
Chairperson & CEO · Director
日期
Jun 4
股数
560
均价
$550.46
总金额
$308K
⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股
▸ 数据来源:SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 UTHR 内幕交易
UTHR 内幕交易
United Therapeutics Corporation(UTHR)内幕交易数据来源于公司内部人(包括ROTHBLATT MARTINE A (Chairperson & CEO · Director), EDGEMOND JAMES (CFO AND TREASURER), MAHON PAUL A (EVP & GENERAL COUNSEL))提交的SEC Form 4申报文件。过去12个月内,3位内部人向SEC提交了交易申报。UTHR内部人近期主要在卖出,这可能反映预设的10b5-1计划执行,而非方向性判断。
如需查看United Therapeutics Corporation机构持仓比例和内部人持股百分比,请访问持仓(Ownership)标签页 → Ownership tab →
常见问题
UTHR 内幕交易 · 5个问题United Therapeutics Corporation(UTHR)的内部人包括高管和董事,如ROTHBLATT MARTINE A (Chairperson & CEO · Director), EDGEMOND JAMES (CFO AND TREASURER), MAHON PAUL A (EVP & GENERAL COUNSEL)等。过去12个月内,3位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源:FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 8, 2026